Evidence map›Paper›PMID 32523307›Full record

ReviewWorld journal of gastroenterology2020

Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes.

Ilenia Bartolini, Matteo Risaliti, Maria Novella Ringressi, Filippo Melli, Giulia Nannini, Amedeo Amedei, Paolo Muiesan, Antonio Taddei

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. The perioperative microbiome of patients undergoing rectal cancer surgery: A pilot study.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The role of IL-22 in cancer.Medical oncology (Northwood, London, England) · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ilenia BartoliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Matteo RisalitiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Maria Novella RingressiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Filippo MelliDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Giulia NanniniDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Amedeo AmedeiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy. amedeo.amedei@unifi.it.
Paolo MuiesanDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Antonio TaddeiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human body is colonized by a huge amount of microorganisms mostly located in the gastrointestinal tract. These dynamic communities, the environment and their metabolites constitute the microbiota. Growing data suggests a causal role of a dysbiotic microbiota in several pathologies, such as metabolic and neurological disorders, immunity dysregulations and cancer, especially the well-studied colorectal cancer development. However, many were preclinical studies and a complete knowledge of the pathogenetic mechanisms in humans is still absent. The gut microbiota can exert direct or indirect effects in different phases of colorectal cancer genesis. For example,

Indexed as

ColonColorectal NeoplasmsDisease-Free SurvivalDysbiosisGastrointestinal MicrobiomeHost Microbial InteractionsHumansImmunity, MucosalIntestinal MucosaNeoplasm Recurrence, LocalPostoperative ComplicationsPrognosisRectumTime FactorsTreatment OutcomeChemo-resistanceColorectal cancerIntestinal microbiotaTherapeutic strategies

Identifiers

PMID32523307
PMCPMC7265137
OpenAlexW3029745610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.